Genetics of allergic and immunoregulatory disorders

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Philadelphia [u.a.] Saunders 2002
Schriftenreihe:Immunology and allergy clinics of North America 22,2
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV014600289
003 DE-604
005 20020807
007 t|
008 020730s2002 xx ad|| |||| 00||| eng d
035 |a (OCoLC)50392139 
035 |a (DE-599)BVBBV014600289 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-355  |a DE-29  |a DE-578 
050 0 |a RC583 
084 |a XD 2800  |0 (DE-625)152549:12905  |2 rvk 
245 1 0 |a Genetics of allergic and immunoregulatory disorders  |c Kathleen E. Sullivan ..., guest eds. 
264 1 |a Philadelphia [u.a.]  |b Saunders  |c 2002 
300 |a XII S., S. 180 - 382  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Immunology and allergy clinics of North America  |v 22,2 
650 4 |a Allergy  |x Genetic aspects 
650 4 |a Immune response  |v Regulations 
650 4 |a Immunologic diseases  |x Genetic aspects 
650 0 7 |a Genetik  |0 (DE-588)4071711-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Allergie  |0 (DE-588)4001257-8  |2 gnd  |9 rswk-swf 
650 0 7 |a Immunsystem  |0 (DE-588)4026643-6  |2 gnd  |9 rswk-swf 
650 0 7 |a Krankheit  |0 (DE-588)4032844-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Regulation  |0 (DE-588)4049075-0  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Immunsystem  |0 (DE-588)4026643-6  |D s 
689 0 1 |a Regulation  |0 (DE-588)4049075-0  |D s 
689 0 2 |a Krankheit  |0 (DE-588)4032844-2  |D s 
689 0 3 |a Genetik  |0 (DE-588)4071711-2  |D s 
689 0 |5 DE-604 
689 1 0 |a Allergie  |0 (DE-588)4001257-8  |D s 
689 1 1 |a Genetik  |0 (DE-588)4071711-2  |D s 
689 1 |5 DE-604 
700 1 |a Sullivan, Kathleen E.  |e Sonstige  |4 oth 
830 0 |a Immunology and allergy clinics of North America  |v 22,2  |w (DE-604)BV000645505  |9 22,2 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009923906&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-009923906 

Datensatz im Suchindex

DE-BY-UBR_call_number 01/21.X0989
DE-BY-UBR_katkey 3328308
DE-BY-UBR_location 00
DE-BY-UBR_media_number 069030801274
_version_ 1822712326678118400
adam_text GENETICS OF ALLERGIC Alffil ^^^^^^SBBBKBBM CONTENTS Preface xj Kathleen E. Sullivan and Jonathan M. Spergel Genetics of Asthma 179 Michael J. Larj, Deborah A. Meyers, and Eugene R. Bleecker Multiple genes influence susceptibility to asthma, and disease expres¬ sion is affected by genetic and environmental factors. Genetic studies of complex disorders such as asthma require the collaborative efforts of investigators who are involved in phenotype definition, molecular and statistical genetics, and biologic studies. Determining the specif¬ ic role of each gene in the development of asthma and bronchial hyperresponsiveness and correlations of phenotype to genotype are important areas of research. Combined genetic, molecular, and clini¬ cal studies can lead to improved therapies and better techniques for early diagnosis of these disorders. By understanding the basic genet¬ ic mechanisms that lead to the development of allergy and asthma, new therapeutic interventions can be developed that modify the development and clinical progression of these disorders. Genetics of Atopic Dermatitis 199 William O.C.M. Cookson, John I. Harper, and Miriam F. Moffatt Atopic dermatitis (AD) is a common skin disorder that is typified by itchy, inflamed skin. Although atopy is a prominent feature of AD, the cause of the disease is unknown, and approximately 10% of patients with AD are not atopic. The disease is under strong genetic control, so identification of the genes and genetic variants underlying AD might lead to new treatments and better classification of children with the disease. Preliminary genetic studies have identified that the genes or clusters of genes that affect the barrier functions of the skin are as important as genes that might modify the atopic process. These genes might influence other diseases, including psoriasis. The find¬ ings emphasize that the barrier function of the skin is not merely pas¬ sive, and the polymorphic nature of genes and gene families expressed in the skin suggest a polyvalent response to a number of different stimuli, including infections. VOLUME 22 • NUMBER 2 . MAY 2002 v The Genetics of Food Allergy 211 Scott H. Sicherer Food allergy is a complex trait with phenotypic expression that undoubtedly is determined by multiple genes with major and minor influences impacted by gene gene and gene environment interactions. Food allergy is not a single disorder but a variety of clinical manifestations that are attributed to adverse immunologic responses to food proteins. Successful genetic dissection of food allergy must begin with a clear description of a particular pheno type. This article reviews the challenges in defining various phenotypes of food allergy the progress in determining the genetic basis of food allergy, and the future directions for the investigation of the genes involved in this complex disease. The Pharmacogenetics of Asthma and Allergic Disease 223 Josephine Hjoberg, Jeffrey M. Drazen, Lyle J. Palmer, Scott T. Weiss, and Eric S. Silverman There is great interindividual variability in the response to asthma medications, and a substantial portion of this variability has a genetic basis. Pharmacogenomics is a rapidly evolving discipline and approach to patient care that uses genetic information and genomic technologies to identify underlying mechanisms that are responsible for these variable therapeutic responses. In this article, the pharma cogenetic principles in the context of asthma are described. Several examples of polymorphisms in genes that impact the efficacy of P2 agonists and antileukotriene drugs have been identified and are discussed. Analysis of polymorphisms likely is to be used routinely in clinical practice for optimizing asthma drug therapy. Genetics of Obstructive Airways Disease: Cystic Fibrosis, a 1 Antitrypsin Deficiency, and Hermansky Pudlak Syndrome 243 Eva Halapi and Hakon Hakonarson Unlike asthma and chronic obstructive pulmonary disease (COPD), which are two of the most common chronic diseases that are attributed to complex interactions between the environment and multiple unknown genes, most respiratory disorders that show Mendelian inheritance patterns are relatively rare and are caused by genetic defects that have been well characterized. Cystic fibrosis (CF) is the most common among these monogenetic diseases. With the discovery of the gene for the CF transmembrane conductance regu¬ lator (CFTR), there has been a dramatic change in the understanding of the genetic defect and molecular mechanisms involved in CF. Together with a 1 antitrypsin (A 1 AT) deficiency, CF has become the most intensively investigated monogenetic disorder and a prototype research model of human lung disease. Important knowledge of disease genes and associated molecular pathways has been derived from these disease models to better understand the development and progression of COPD. This article reviews the evidence in support of genetic causes of CF, A 1AT deficiency, and Hermansky Pudlak vi CONTENTS syndrome. Although significant progress has been made in the field of Mendelian genetics in the past 2 decades, this progress in part has translated only into effective therapy, and the genetics of most com¬ plex disorders remain unresolved. Genetic Syndromes Associated with Immunodeficiency 261 Jeffrey E. Ming, E. Richard Stiehm, and John M. Graham, Jr A number of conditions with immune deficiency also have clinical features that are not associated directly with the immunologic defect. These syndromic immunodeficiencies can have abnormalities in a number of organ systems. This article discusses several disorders in which advances have led to a greater understanding of the genetic basis of these syndromes. The finding of immune deficits in a number of defined syndromes with congenital anomalies suggests that an underlying genetic syndrome should be considered in patients in whom a significant nonimmune feature is present. Hemophagocytic Lymphohistiocytosis 281 Alexandra H. Filipovich The current understanding regarding the etiology and pathogenesis of hemophagocytic lymphohistiocytosis (HLH) is described. Diagnostic criteria for clinical and laboratory diagnosis, as well as effective therapies, are reviewed. Chediak Higashi and Griscelli Syndromes 301 Genevieve de Saint Basile Chediak Higashi syndrome and Griscelli syndrome are immune disorders that are characterized by a severe and often fatal hemophagocytic syndrome (HPS). Progress has been made in the characterization and understanding of the molecular basis involved in these inherited disorders. Defects in the CHS1/LYST protein in Chediak Higashi syndrome and in the RAB27A protein in Griscelli syndrome lead to impairment of intracellular trafficking and secretion of several lysosomal proteins, including melanin from melanocytes and lytic enzymes from cytotoxic cells. These secretory defects cause hypopigmentation and a HPS, symptoms that characterize these two disorders. A neurologic form of Griscelli syndrome is caused by a deficiency in the molecular motor protein myosin Va. The molecular characterization of these two condi¬ tions has identified new effectors of the secretory pathway and highlighted the pathway s determinant role in the regulation of lymphocyte homeostasis. X linked Lymphoproliferative Disease 319 Kim E. Nichols and Thomas G. Gross X linked lymphoproliferative disease (XLP) is an inherited immune defect caused by germline mutations in SH2D1A (SH2 CONTENTS vii domain containing gene 1A; also known as DSHP, SAP), a gene that encodes a small adaptor protein expressed in T, NK, and some B cells. The clinical features of XLP are variable and include fulminant infectious mononucleosis, lymphoma, and hypogam maglobulinemia. Studies of the SH2D1A protein revealed impor¬ tant pathways regulating antiviral immunity. By interacting with specific cell surface receptors, such as 2B4 (CD244), SLAM (CD150), and NTB A, SH2D1A might regulate important aspects of immune cell function, including NK cell cytotoxicity, T cell proliferation, and Tj jl cytokine secretion. Abnormalities in SH2D1A amino acid composition and protein expression levels seem to cause aberrant lymphocyte activation, contributing to the dysregulated immune response that characterizes XLP. Autoimmune Lymphoprolif erative Syndrome: A Genetic Disorder of Abnormal Lymphocyte Apoptosis 339 Jack J.H. Bleesing Fas mediated apoptosis has an important role in the maintenance of a homeostatic balance between lymphocyte survival and death. This role is underscored by three consequences of a genetic dis¬ order of abnormal Fas mediated apoptosis, referred to as auto¬ immune lymphoproliferative syndrome. Abnormal proliferation of lymphocytes increases the risk for malignancies and results in lymphadenopathy, hepatosplenomegaly and hypersplenism, failure to remove autoreactive lymphocytes (associated with autoimmunity), and inappropriate survival of lymphocytes. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X Linked Syndrome and the Scurfy Mutant Mouse 357 Hans D. Ochs, Roli Khattri, Craig L. Bennett, and Mary E. Brunkow IPEX is a rare X linked syndrome characterized by neonatal infan¬ tile insulin dependent diabetes mellitus, enteropathy, endocrino pathy, eczema and severe infections with variable immune dysfunction. Scurfy, an X linked lethal disorder of immune regula¬ tion, is the murine equivalent of IPEX, providing a model for the human disease. The gene responsible for scurfy has recently been identified by positional cloning. The scurfy/IPEX gene is a member of a family of transcriptional regulators that have in common a forkhead winged helix DNA binding domain. The cloning of the human ortholog of the mouse gene confirmed that FOXP3 codes for the immune specific DNA binding protein responsible for IPEX. Missense and nonsense mutations, microdeletions, elimination of the downstream stop codon and mutations of the polyadenylation sig¬ nal have been identified in affected members of families with clas¬ sic IPEX. It has been suggested that FOXP3 acts as a trascriptional repressor in vivo. Treatment with Cyclosporin A or FK506 improves the clinical course and HLA identical bone marrow transplantation appears to provide a permanent cure. Index 369 viii CONTENTS
any_adam_object 1
building Verbundindex
bvnumber BV014600289
callnumber-first R - Medicine
callnumber-label RC583
callnumber-raw RC583
callnumber-search RC583
callnumber-sort RC 3583
callnumber-subject RC - Internal Medicine
classification_rvk XD 2800
ctrlnum (OCoLC)50392139
(DE-599)BVBBV014600289
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02064nam a2200505 cb4500</leader><controlfield tag="001">BV014600289</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20020807 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">020730s2002 xx ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50392139</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014600289</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC583</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 2800</subfield><subfield code="0">(DE-625)152549:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Genetics of allergic and immunoregulatory disorders</subfield><subfield code="c">Kathleen E. Sullivan ..., guest eds.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Saunders</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII S., S. 180 - 382</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Immunology and allergy clinics of North America</subfield><subfield code="v">22,2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Allergy</subfield><subfield code="x">Genetic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immune response</subfield><subfield code="v">Regulations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic diseases</subfield><subfield code="x">Genetic aspects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Genetik</subfield><subfield code="0">(DE-588)4071711-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Allergie</subfield><subfield code="0">(DE-588)4001257-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunsystem</subfield><subfield code="0">(DE-588)4026643-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krankheit</subfield><subfield code="0">(DE-588)4032844-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Regulation</subfield><subfield code="0">(DE-588)4049075-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunsystem</subfield><subfield code="0">(DE-588)4026643-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Regulation</subfield><subfield code="0">(DE-588)4049075-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Krankheit</subfield><subfield code="0">(DE-588)4032844-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Genetik</subfield><subfield code="0">(DE-588)4071711-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Allergie</subfield><subfield code="0">(DE-588)4001257-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Genetik</subfield><subfield code="0">(DE-588)4071711-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sullivan, Kathleen E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Immunology and allergy clinics of North America</subfield><subfield code="v">22,2</subfield><subfield code="w">(DE-604)BV000645505</subfield><subfield code="9">22,2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=009923906&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009923906</subfield></datafield></record></collection>
genre (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV014600289
illustrated Illustrated
indexdate 2024-12-23T15:58:00Z
institution BVB
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-009923906
oclc_num 50392139
open_access_boolean
owner DE-355
DE-BY-UBR
DE-29
DE-578
owner_facet DE-355
DE-BY-UBR
DE-29
DE-578
physical XII S., S. 180 - 382 Ill., graph. Darst.
publishDate 2002
publishDateSearch 2002
publishDateSort 2002
publisher Saunders
record_format marc
series Immunology and allergy clinics of North America
series2 Immunology and allergy clinics of North America
spellingShingle Genetics of allergic and immunoregulatory disorders
Immunology and allergy clinics of North America
Allergy Genetic aspects
Immune response Regulations
Immunologic diseases Genetic aspects
Genetik (DE-588)4071711-2 gnd
Allergie (DE-588)4001257-8 gnd
Immunsystem (DE-588)4026643-6 gnd
Krankheit (DE-588)4032844-2 gnd
Regulation (DE-588)4049075-0 gnd
subject_GND (DE-588)4071711-2
(DE-588)4001257-8
(DE-588)4026643-6
(DE-588)4032844-2
(DE-588)4049075-0
(DE-588)4143413-4
title Genetics of allergic and immunoregulatory disorders
title_auth Genetics of allergic and immunoregulatory disorders
title_exact_search Genetics of allergic and immunoregulatory disorders
title_full Genetics of allergic and immunoregulatory disorders Kathleen E. Sullivan ..., guest eds.
title_fullStr Genetics of allergic and immunoregulatory disorders Kathleen E. Sullivan ..., guest eds.
title_full_unstemmed Genetics of allergic and immunoregulatory disorders Kathleen E. Sullivan ..., guest eds.
title_short Genetics of allergic and immunoregulatory disorders
title_sort genetics of allergic and immunoregulatory disorders
topic Allergy Genetic aspects
Immune response Regulations
Immunologic diseases Genetic aspects
Genetik (DE-588)4071711-2 gnd
Allergie (DE-588)4001257-8 gnd
Immunsystem (DE-588)4026643-6 gnd
Krankheit (DE-588)4032844-2 gnd
Regulation (DE-588)4049075-0 gnd
topic_facet Allergy Genetic aspects
Immune response Regulations
Immunologic diseases Genetic aspects
Genetik
Allergie
Immunsystem
Krankheit
Regulation
Aufsatzsammlung
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009923906&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link (DE-604)BV000645505
work_keys_str_mv AT sullivankathleene geneticsofallergicandimmunoregulatorydisorders